Aminoglycosides Market Size to Reach USD 2.16 Billion by 2028 – Reports and Data

Rising incidences of animal disease outbreak, increasing adoption of digital health agenda by organizations like WHO and ERS, high production of generic drugs and increasing cases of bacterial infections are key factors fueling global market growth  

The global aminoglycosides market size is expected to reach USD 2.16 Billion in 2028 and register a CAGR of 3.7%, according to the latest report by Reports and Data. Increasing usage of aminoglycosides for treating various bacterial infections of the lung, abdomen, urinary tract and advancements in pharmaceutical and medical sector are key factors driving global market revenue growth. 

 Aminoglycosides are broad-spectrum antibiotics that inhibit protein synthesis and are used to treat severe gram-negative infections in humans and animals. One of the major factors driving global market revenue growth is the increasing number of tuberculosis patients worldwide. In addition, increasing number of generic drugs, presence of UNITAID and Global Drug Facility for managing diagnosis and treatment of tuberculosis, and increasing cases of multi-drug resistant tuberculosis (MDR-TB) are key factors further fueling global market growth. Moreover, increasing investments by government and private sectors for ongoing reach activities, increasing public awareness, and favorable government policies for healthcare infrastructure in several countries is expected to boost market revenue growth going ahead. 

However, adverse effects such as renal toxicity, hearing loss, seizures caused by aminoglycosides, and reduction in sale due to steady decline in consumption of some antibiotics are some key restraints expected to hamper global market growth to a certain extent over the forecast period. 

Access Free sample PDF Copy of the Report @

Some key highlights from the report:

  • Among the drug class, the gentamicin segment accounted for largest market share in 2020 and is expected to maintain its dominant position throughout the forecast period. Gentamicin is a cost-effective, broad-spectrum antibacterial drug used for several infectious diseases like pneumonia, sepsis, bone infections, UTI, and pelvic inflammatory diseases. 
  • The injectable segment accounted for largest market share of 22% in 2020 and is expected to account for significant revenue growth between 2021 and 2028. Injectable route through intramuscular or intravenous is preferred for human usage as it quickly absorbs and shows rapid effect and is commonly used for treating life-threatening infections.
  • Among the application segments, the respiratory segment is expected to register highest CAGR over the forecast period. Rising prevalence of tuberculosis along with multidrug-resistant tuberculosis and rising need for suitable treatment is boosting demand for aminoglycosides. 
  • Asia Pacific is expected to account for largest revenue share during the forecast period. China, India, and Japan are key contributors in Asia Pacific. High revenue growth is attributed to increasing incidences of tuberculosis, presence of generic drug manufacturers, increasing geriatric population, and availability of multidrug like kanamycin and capreomycin. 
  • North America is expected to account for significant revenue growth over the forecast period. Factors such as rapid growth in the pharmaceutical sector, increasing incidences of bacterial infections, rising awareness about early detection and diagnosis, and availability of advanced treatment are boosting market revenue growth. 
  • Key players operating in the global aminoglycosides market are Vega Pharma Ltd., Kremoint Pharma Pvt. Ltd, Xian Wison Biological Technology Co., Ltd., Jiangxi Bolai Pharmacy Co., Ltd., Taiwan Fructose, Medson Pharmaceuticals, Hangzhou Uniwise International Co., Ltd., Yi Chang Veterinary Medicine Factory, HuvePharma, and Medico Remedies Pvt. Ltd. 

Request for Custom Research @

For this study, Reports and Data has segmented the global aminoglycosides market based on drug, mode of administration, application, and region:

Drug Outlook (Revenue, USD Billion, 2018 - 2028)

  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Paromomycin
  • Streptomycin
  • Kanamycin

Mode of Administration Outlook (Revenue, USD Billion, 2018 - 2028)

  • Feed
  • Injectable
  • Intra-mammary
  • Topical
  • Oral

Application Outlook (Revenue, USD Billion, 2018 - 2028)

  • Veterinary
  • Skin
  • Respiratory
  • UTI & Pelvic Disease
  • Neonatal Sepsis

Buy now your Exclusive copy of Report @

Regional Outlook (Revenue, USD Billion, 2018 - 2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest Of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

Explore Reports and Data's Prime Analysis of the global Pharmaceutical Industry:

Neuroscience Antibodies and Assays Market Size, Share & Analysis, By Product (Consumables (Reagents, Antibodies, Assay Kits), Instruments), By Technology (Immunoassays, Molecular Diagnostics, Clinical Chemistry, Others), By Application (Research, In Vitro Diagnostics, Drug Discovery & Development), By End-Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers), and By Region, Forecast To 2028

Clarithromycin Tablets Market Size, Share & Analysis, By Type (250 mg Tablets, 500 mg Tablets), By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Forecast To 2028

Mannitol Injection Market Size, Share & Analysis, By Product Type (5g/100 ml, 10g/100 ml, 15g/100 ml, 20g/100 ml, 25g/100 ml), By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region, Forecast To 2028

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


Read Full Press Release:

Back to news